Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:2589-2591
Published online before print April 30, 2009, doi: 10.1161/STROKEAHA.108.544346
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/7/2589    most recent
STROKEAHA.108.544346v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Caty, G. D.
Right arrow Articles by Lejeune, T. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caty, G. D.
Right arrow Articles by Lejeune, T. M.
Related Collections
Right arrow Rehabilitation, Stroke

(Stroke. 2009;40:2589.)
© 2009 American Heart Association, Inc.


Research Letters

Effect of Upper Limb Botulinum Toxin Injections on Impairment, Activity, Participation, and Quality of Life Among Stroke Patients

Gilles D. Caty, MD; Christine Detrembleur, PhD; Corinne Bleyenheuft, MD; Thierry Deltombe, MD Thierry M. Lejeune, MD

From the Université catholique de Louvain (G.D.C., C.D., C.B., T.M.L.), Cliniques universitaires Saint-Luc, Physical Medicine and Rehabilitation Department, Brussels, Belgium; and the Université catholique de Louvain (T.D.), Cliniques universitaires de Mont-Godinne, Physical Medicine and Rehabilitation Department, Yvoir, Belgium.

Correspondence to Professor T.M. Lejeune, Université catholique de Louvain, Cliniques universitaires Saint-Luc, Physical Medicine and Rehabilitation Department, Avenue Hippocrate 10, 1200 Brussels, Belgium. E-mail Thierry.Lejeune{at}uclouvain.be

Background and Purpose— The purpose of this study was to study the effect of Botulinum toxin type A (BoNT-A) injections in spastic upper limb muscles on impairment, activity, participation and quality of life in chronic stroke patients.

Methods— BoNT-A (Dysport) was injected into several upper limb spastic muscles in a group of 20 patients. Neurological impairment (muscle tone and strength, dexterity, SIAS), activity (ABILHAND), participation (SATIS-Stroke), and quality of life (SF36) were assessed before and 2 months after the injections.

Results— BoNT-A injections improved muscle tone, but had no impact on dexterity, manual ability, social participation, and quality of life.

Conclusions— In this study, BoNT-A injections in spastic upper limbs significantly reduced neurological impairments, but had no functional impact.


Key Words: stroke • arm • spasticity • Botulinum toxins